Risk Assessment of Toxaphene and its Breakdown Products: Time for a Change?

REFERENCES

• Agency for Toxic Substances and Disease Registry, and Toxicological profile for toxaphene U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA, (1996).
   Google Scholar
• T. Bartos, M. Skarek, P. Cupr, P. Kosubova, and I. Holoubek. (2005). Genotoxic activity of a technical toxaphene mixture and its photodegradation products in SOS genotoxicity tests. Mutation Res. 565:113–120.
   PubMedGoogle Scholar
• J. M. Battershill, and R. J. Fielder. (1998). Mouse-specific carcinogens: An assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice. Hum. Exp. Toxicol. 17:193–205.
   PubMed Web of Science ®Google Scholar
• H. T. Besselink, E. Nixon, B. McHugh, J. Klungsøyr, and A. Brouwer. (2000). In vitro and in vivo tumor promoting potency of technical toxaphene, UV-irradiated toxaphene, and biotransformed toxaphene. Organohalogen Compounds 47:113–116.
   Google Scholar
• S. J. Borghoff, B. G. Short, and J. A. Swenberg. (1990). Biochemical mechanisms and pathobiology of ά2u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol. 30:349–367.
   PubMed Web of Science ®Google Scholar
• M. Breña-Valle, and J Serment-Guerrero. (1998). SOS induction by gamma-radiation in Escherichia coli strains defective in repair and/or recombination mechanisms. Mutagensis 13 (6):637–641.
   PubMedGoogle Scholar
• N. G. Carmichael, H. Enzmann, I. Pate, and F. Waechter. (1997). The significance of mouse liver tumor formation for carcinogenic risk assessment: Results and conclusions from a survey of ten years of testing by the agrochemical industry. Environ. Health Perspect. 105:1196–1203.
   PubMed Web of Science ®Google Scholar
• M. Coelhan, and H. Parlar. (1996). The nomenclature of chlorinated bornanes and camphenes relevant to toxaphene. Chemosphere 32:217–228.
   Google Scholar
• H.-J. de Geus, H. Besselink, A. Brouwer, J. Klungsøyr, B. McHugh, E. Nixon, G. G. Rimkus, P. G. Wester, and J. de Boer. (1999). Environmental occurrence, analysis, and toxicology of toxaphene compounds. Environ. Health Perspect. 107 (Suppl. 1):115–144.
   PubMedGoogle Scholar
• D. J. Fitzgerald, and H. Yamasaki. (1990). Tumor promotion: Models and assay systems. Teratogen. Carcinogen. Mutagen. 10:89–102.
   PubMedGoogle Scholar
• H. J. Geyer, A. Kaune, K. W. Schramm, G. Rimkus, I. Scheunert, R. Bruggemann, J. Altschuh, C. E. Steinberg, W. Vetter, A. Kettrup, and D. C. Muir. (1999). Predicting bioconcentration factors (BCFs) of polychlorinated bornane (toxaphene) congeners in fish and comparison with bioaccumulation factors (BAFs) in biota from the aquatic environment. Chemosphere 39:655–663.
   PubMedGoogle Scholar
• J. I. Goodman, D. J. Brusick, W. M. Busey, S. M. Cohen, J. C. Lamb, and T. B. Starr. (2000). Reevaluation of the cancer potency factor of toxaphene: Recommendations from a peer review panel. Toxicol Sci. 55:3–16.
   PubMed Web of Science ®Google Scholar
• J. I. Goodman. (1998). The traditional toxicologic paradigm is correct: Dose influences mechanism. Environ. Health Perspect. 106 (Suppl. 1):285–288.
   PubMedGoogle Scholar
• J. I. Goodman, and R. E. Watson. (2002). Altered DNA methylation: A secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42:501–525.
   PubMed Web of Science ®Google Scholar
• G. C. Hard, I. S. Rodgers, K. P. Baetcke, W. L. Richards, R. E. McGaughy, and L. R. Valcovic. (1993). Hazard evaluation of chemicals that cause accumulation of ά2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ. Health Perspect. 99:313–349.
   PubMed Web of Science ®Google Scholar
• C. C. Hedli, R. Snyder, F. K. Kinoshita, and M. Steinberg. (1998). Investigation of hepatic cytochrome P-450 enzyme induction and DNA adduct formation in male CD/1 mice following oral administration of toxaphene. J. Appl. Toxicol. 18:173–178.
   PubMed Web of Science ®Google Scholar
• R. N. Hill, T. M. Crisp, P. M. Hurley, S. L. Rosenthal, and D. V. Singh. Assessment of Thyroid Follicular Cell Tumors U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC, (1998).
   Google Scholar
• M. P. Holsapple, H. C. Pitot, S. M. Cohen, A. R. Boobis, J. E. Klaunig, T. Pastoor, V. L. Dellarco, and Y. P. Dragan. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 89:51–56.
   PubMed Web of Science ®Google Scholar
• G. D. Jahnke, N. Y. Choksi, J. A. Moore, and M. D. Shelby. (2004). Thyroid toxicants: Assessing reproductive health effects. Environ. Health Perspect. 112:363–368.
   PubMed Web of Science ®Google Scholar
• L. M. Kamendulis, J. S. Isenberg, J. H. Smith, G. PughJr., A. W. Lington, and J. E. Klaunig. (2002). Comparative effects of phthalate monoesters on gap junctional intercellular communication and peroxisome proliferation in rodent and primate hepatocytes. J. Toxicol. Environ. Health A 65:569–588.
   PubMed Web of Science ®Google Scholar
• K. S. Kang, M. R. Wilson, T. Hayashi, C. C. Chang, and J. E. Trosko. (1996). Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures. Environ. Health Perspect. 104:192–200.
   PubMed Web of Science ®Google Scholar
• P. Korytar, L. L. van Stee, P. E. Leonards, J. de Boer, and U. A. Brinkman. (2003). Attempt to unravel the composition of toxaphene by comprehensive two-dimensional gas chromatography with selective detection. J. Chromatogr. A 994:179–189.
   PubMed Web of Science ®Google Scholar
• L. D. Lehman-McKeeman, M. I. Rivera-Torres, and D. Caudill. (1990). Lysosomal degradation of alpha 2u-globulin and alpha 2u-globulin-xenobiotic conjugates. Toxicol. Appl. Pharmacol. 103:539–548.
   PubMed Web of Science ®Google Scholar
• P. E. Leonards, H. Besselink, A. Brouwer, B. McHugh, E. Nixon, G. Rimkus, and J. de Boer. (2006). Toxicological risks to humans of toxaphene residues in fish. Organohalogen Compounds 68:1414–1417.
   Google Scholar
• Litton Bionetics, and Carcinogenic Evaluation in Mice: Toxaphene. Final Report (1978) Prepared by Litton Bionetics, Inc. Kensington, MD for Hercules, Inc., Wilmington, DE. LBI Project 20602.
   Google Scholar
• Litton Bionetics, and Evaluation of Carcinogenic Potential in Hamsters: Toxaphene. Final Report (1979) Prepared by Litton Bionetics, Inc., Kensington, MD, for Hercules, Inc., Wilmington, DE. LBI Project 20601.
   Google Scholar
• K. A. Maruya, S. G. Wakeham, W. Vetter, and L. Francendese. (2000). Prominent chlorobornane residues in estuarine sediments contaminated with toxaphene. Environ. Toxicol. Chem. 19:2198–2203.
   Web of Science ®Google Scholar
• MATT, and Investigation into the Monitoring, Analysis and Toxicity of Toxaphene in Marine Foodstuffs European Union, Brussels, (2000) Final Report: FAIR CT PL.96.3131.
   Google Scholar
• M. E. Meek, J. R. Bucher, S. M. Cohen, V. Dellarco, R. N. Hill, L. D. Lehman-McKeeman, D. G. Longfellow, T. Pastoor, J. Seed, and D. E. Patton. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33:591–653.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute, and Bioassay of Toxaphene for Possible Carcinogenicity National Institute of Health, U.S. Department of Health, Education and Welfare, Bethesda, MD, (1979) Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, NCIDHEW Publication No. (NIH) 79-837.
   Google Scholar
• National Toxicology Program, and Report on Carcinogens, 11th ed.. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Washington, DC, (2005).
   Google Scholar
• P. Quillardet, O. Huisman, R. D'Ari, and M. Hofnung. (1982). The SOS chromotest: Direct assay of the expression of gene sfiA as a measure of genotoxicity of chemicals. Biochimie. 64 (8–9):797–801.
   PubMedGoogle Scholar
• L. Ritter, C. Totman, K. Krishnan, R. Carrier, A. Vézina, and V. Morisset. (2007). Deriving uncertainty factors for threshold chemical contaminants in drinking water. J. Toxicol. Environ. Health B 10:527–557.
   PubMed Web of Science ®Google Scholar
• M. A. Saleh. (1991). Toxaphene: Chemistry, biochemistry, toxicity and environmental fate. Rev. Environ. Contam. Toxicol. 118:1–85.
   PubMed Web of Science ®Google Scholar
• T. J. Schrader, B. G. Boyes, T. I. Matula, C. Heroux-Metcalf, I. Langlois, and R. H. Downie. (1998). In vitro investigation of toxaphene genotoxicity in S. typhimurium and Chinese hamster V79 lung fibroblasts. Mutat. Res. 413:159–168.
   PubMedGoogle Scholar
• T. Simon, and R. Manning. (2006). Development of a reference dose for the persistent congeners of weathered toxaphene based on in vivo and in vitro effects related to tumor promotion. Regul. Toxicol. Pharmacol. 44:268–281.
   PubMed Web of Science ®Google Scholar
• M. Steinberg, F. K. Kinoshita, and M. Ballantyne. (1998). Mutagenicity studies with toxaphene congeners. Organohalogen Compounds 35:243–246.
   Google Scholar
• J. A. Swenberg, and L. D. Lehman-McKeeman. ά2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male ratsSpecies Differences in Thyroid, Kidney, and Urinary Bladder CarcinogenesisC. C. Capen, E. Dybing, J. M. Rice, and J. D. Wilbourn. IARC, Lyon, France, (1999) 95–118. IARC Scientific Publication No. 147.
   Google Scholar
• J. E. Trosko, C. Jone, and C. C. Chang. (1987). Inhibition of gap junctional-mediated intercellular communication in vitro by aldrin, dieldrin, and toxaphene: A possible cellular mechanism for their tumor-promoting and neurotoxic effects. Mol. Toxicol. 1:83–93.
   PubMedGoogle Scholar
• J. E. Trosko, and R. J. Ruch. (1998). Cell–cell communication in carcinogenesis. Front. Biosci. 3:d208–36.
   PubMedGoogle Scholar
• H. Tsuda, S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Wakabayashi, and M. A. Moore. (2003). Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: Evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work. Toxicol. Pathol. 31:80–86.
   PubMed Web of Science ®Google Scholar
• University of California Berkeley Laboratory, and The Carcinogenic Potency Database (CPDB) (2007) http://potency.berkeley.edu.
   Google Scholar
• U.S. Environmental Protection Agency, and Guidelines for Carcinogen Risk Assessment U.S. Environmental Protection Agency, Washington, DC, (1986).
   Google Scholar
• U.S. Environmental Protection Agency, and Alpha-u2-globulin: Association With Chemically Induced Renal Toxicity and Neoplasia in the Male Rat, Washington, DC, (1991) U.S. EPA/625/3–91/019F.
   Google Scholar
• U.S. Environmental Protection Agency, and Guidelines for Carcinogen Risk Assessment U.S. Environmental Protection Agency, Washington, DC, (2005).
   Google Scholar
• U.S. Environmental Protection Agency Integrated Risk Information System, and Toxaphene, (1991) http://www.epa.gov/iris/subst/0346.htm.
   Google Scholar
• W. Vetter, and D. Kirchberg. (2001). Production of toxaphene enantiomers by enantioselective HPLC after isolation of the compounds from an anaerobically degraded technical mixture. Environ. Sci. Technol. 35 (5):960–965.
   PubMedGoogle Scholar
• R. S. Waritz, M. Steinberg, F. Kinoshita, C. L. Kelly, and W Richter. (1996). Thyroid function and thyroid tumors in toxaphene-treated rats. Regul. Toxicol. Pharmacol. 24:184–192.
   PubMedGoogle Scholar
• J. Whysner, P. M. Ross, and G. M. Williams. (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71:153–191.
   PubMed Web of Science ®Google Scholar
• J. C. Young, and A. D. Freeman. Comparing the Mutagenicity of Toxaphene after aging in Anoxic Soils and Accumulating in Fish, Cincinnati, OH, (2004) Final report for projects R9C-R570-NASA and 1CR234-NASA with the Office of Research and Development of the U.S. Environmental Protection Agency.
   Google Scholar